Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


7th Annual Improving Solubility Conference

26 Feb 2013 - 28 Feb 2013 - Philadelphia, PA, USA



Bookmark and Share


IQPC’s Improving Solubility Conference has become an annual meeting for the scientific community. This year, we will showcase the newest solubility technologies and provide the latest research from established industry leaders in order to provide you with practical, applicable knowledge to effectively improve bioavailability and drug candidate solubility.

The competition in the pharmaceutical market is at an all time high and without solid techniques to drive increased bioavailability of your products, you will be left in the dust. Learn the latest methodologies and technologies to take on this challenge and minimize the time-to-market on your drug pipeline.

Gain access to exclusive case studies on:

•    Approaches to Leverage In-Vitro Data to Hypothesize In-Vivo Data
•    Rational Formulation Design Guided by Biopharmaceutics Modeling and Automated Formulation Screening
•    Designing and Developing Super Saturation Based Drugs
•    Enhancing the In-Vivo Performance Hot-Melt Extrusion
•    Introducing Levitation Technology for the Production of Amorphous Drugs
•    Co-Crystal Development: From Mortar & Pestle to Production
•    Influence of Particle Size on the Ultraviolet Spectrum of Particulate-Containing Solutions
•    Stability Prediction for Amorphous Materials



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!